Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exercise-induced bronchospasm: epidemiology, pathophysiology, and therapy.

F S Virant1

  • 1University of Washington, School of Medicine, Children's Hospital and Medical Center, Seattle 98105.

Medicine and Science in Sports and Exercise
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sinusitis and asthma: associated airway diseases.

Current allergy and asthma reports·2002
Same author

Sinusitis and pediatric asthma.

Pediatric annals·2000
Same author

Discussion of risk of scuba diving in individuals with allergic and respiratory diseases: SCUBA Subcommittee.

The Journal of allergy and clinical immunology·1995
Same author

Allergic rhinitis.

Pediatrics in review·1992
Same author

Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma.

The Journal of allergy and clinical immunology·1991
Same author

Immunologic defects in patients with refractory sinusitis.

Pediatrics·1991

Exercise-induced bronchospasm (EIB) affects many with asthma and allergies. Prompt diagnosis and treatment with beta-adrenergic agonists can improve athletic performance and enjoyment of physical activity.

Area of Science:

  • Pulmonology
  • Sports Medicine
  • Allergy and Immunology

Background:

  • Exercise-induced bronchospasm (EIB) is a prevalent condition, particularly in individuals with chronic asthma and a significant portion of the allergic population.
  • EIB manifests as bronchospasm 5-15 minutes post-exercise, typically resolving within 20-60 minutes.
  • The primary triggers for EIB involve airway cooling and drying, leading to mast cell mediator release in the lungs.

Purpose of the Study:

  • To highlight the clinical significance of Exercise-induced bronchospasm (EIB).
  • To discuss the pathophysiology, diagnosis, and management of EIB.
  • To emphasize the impact of effective EIB treatment on patient quality of life and athletic capabilities.

Main Methods:

  • Review of clinical presentation and triggers of EIB.

Related Experiment Videos

  • Discussion of diagnostic considerations for EIB.
  • Overview of therapeutic strategies for managing EIB.

    • Main Results:

    • Bronchospasm severity correlates with baseline bronchial hyperreactivity and exercise intensity.
    • Pre-exercise administration of beta-adrenergic agonists is the primary treatment.
    • Other effective therapies include cromolyn, theophylline, calcium channel blockers, anticholinergics, and antihistamines.

    Conclusions:

    • Accurate diagnosis of EIB is critical for effective patient management.
    • Appropriate treatment of EIB can significantly enhance athletic performance and enjoyment of physical activities.
    • EIB is a manageable condition that responds well to targeted therapies.